细胞周期蛋白依赖性蛋白激酶5在中枢神经系统发育和神经退行性疾病中的作用

脯氨酸引导的丝/苏氨酸蛋白酶——细胞周期蛋白依赖性蛋白激酶5(cyclin-dependent kinase5,Cdk5)是细胞周期素依赖的蛋白酶家族中一个特殊成员。Cdk5不参与细胞周期调控,其活化需要与神经元内广泛表达的激活因子——p35或p39相结合。正常情况下,Cdk5的转录及活性受到体内相关机制的严格调控。在神经系统发育及成熟阶段,Cdk5通过磷酸化细胞骨架蛋白、信号分子以及调节蛋白等众多底物蛋白的特异性丝/苏氨酸位点,在神经元的迁移分化、存活和突触的发生、信息传递、可塑性等诸多方面发挥重要的作用。此外,在一些病理条件下,p35的病理性剪切和Cdk5/p25的形成所导致的Cdk5活性失调及其亚细胞分布改变则促进了神经元的凋亡或死亡,参与了阿尔茨海默氏病(Alzheimer's disease,AD)、帕金森氏病(Parkinson’s disease,PD)、亨廷顿氏病(Huntington’s disease,HD)以及脊髓侧索硬化症(amyotrophiclateralsclerosis,ALS)等众多神经退行性疾病的发生发展过程。本文综述了Cdk5在中枢神经系统发育和神经退行性疾病中的作用研究方面的进展。     

亚硝基化修饰依赖的蛋白酶体降解途径可抑制细胞周期依赖性蛋白激酶5的活性

正突触间的连接受到多种蛋白质的活性与功能的协调配合,细胞周期依赖性蛋白激酶5(Cyclin-dependent kinase 5,Cdk5)的激活在突触形成过程中发挥重要作用,Cdk5的过度激活可通过减少树突棘数量及下调神经元表面受体NMDA的表达导致突触形成障碍。最近,来自香港理工大学的研究团队发现NO可对Cdk5特异性激活子p35进行亚硝基化修饰,进而介导蛋白酶体降解途径下调p35表达,降低Cdk5活性。研究人员发现,在神经元型一氧化氮合酶(nNOS)敲除小鼠中,海马神经元密度及成熟性均显著下降,神经元表面受体     

DNA损伤反应中细胞周期检查点蛋白p27~(Kip1)表达及其调控机制

为了研究DNA损伤反应中p2 7Kip1的表达及其调控机制 ,应用免疫印迹的实验结果表明 :10Gy 60 Coγ射线照射后 3h ,HeLa细胞中p2 7Kip1蛋白水平开始下降并持续到 2 4h ,进而失去它对CDKs的抑制功能 .Northern印迹结果显示 ,电离辐射 (IR)对p2 7Kip1mRNA表达水平无明显影响 ,说明电离辐射诱导p2 7Kip1表达水平的降低主要与蛋白质降解相关 ,但其具体的调控机制还不清楚 .已知在G1—S期p2 7Kip1蛋白的降低主要依赖细胞周期蛋白E Cdk2激酶将其磷酸化后的泛素化蛋白酶体途径 (ubiquitin proteasomepathway) .酶动力学研究结果揭示 :电离辐射后细胞周期蛋白E Cdk2激酶活性增高 ,12h细胞周期蛋白E Cdk2激酶活性达到最大 .当在照前用细胞周期蛋白E Cdk2抑制剂olomoucine (10 μmol L)抑制细胞周期蛋白E Cdk2激酶活性时 ,p2 7Kip1蛋白表达水平增加 .此外 ,还观察到电离辐射可诱导p2 7Kip1泛素化水平的增高 ,而在使用蛋白酶体抑制剂MG 132 (5 μmol L)处理HeLa细胞后 ,可抑制辐射诱导p2 7Kip1蛋白水平的下调 .研究结果提示 :泛素化蛋白酶体途径参与了辐射诱导P2 7Kip1蛋白表达下调的降解机制 .     

神经元维持不对称性新机制

吗啡是使用广泛的镇痛剂，但长期使用吗啡会带来诸如耐受和成瘾等副作用。北京大学研究人员在细胞周期素激酶5（Cdk5）对吗啡耐受产生及调节机制方面进行研究，取得重要进展。Cdk5属于细胞周期素激酶家族，它通过磷酸化吗啡内源性受体之一delta受体的第二胞内环中161位苏氨酸，影响delta受体膜转运，继而促进吗啡耐受。     

FosB和Glu受体Ⅱ亚型与慢性可卡因成瘾

过去的一段时间里,CREB一直被认为是与药物成瘾有密切关系的明星分子.但随着研究的不断深入发现,急性给予可卡因可引起ΔFosB家族的多种转录因子在伏核暂时性高表达,但慢性给予可卡因却可诱导Fos家族的异型体ΔFosB在伏核长期高表达,类似现象也见于反复给予其他成瘾性药物,因此ΔFosB遂脱颖而出成为又一个新星分子.1999年9月在英国Nature杂志发表的一篇文章报道,ΔFosB的表达增加及其引发的Glu受体Ⅱ亚型的增加可加强慢性给予可卡因引起的成瘾性,这可能与人类成瘾的形成相似.     

Cdk5与学习和记忆的研究进展

越来越多的证据表明,Cdk5通过与大量蛋白相互作用而在学习和记忆过程中发挥重要作用。近来,关于Cdk5的研究结果不仅证实其参与药物成瘾过程中细胞间的通路改变,且其活性与一些神经退行性疾病的发生有关。本文就Cdk5对学习和记忆的影响及其相关机制的研究进展予以综述。     

白藜芦醇甙对慢性酒精中毒大鼠学习记忆及海马Cdk5激酶活性的影响

目的:研究白藜芦醇甙对慢性酒精中毒大鼠学习记忆及海马细胞周期依赖性蛋白激酶5(Cdk5)活性的影响。方法:40只大鼠随机分为4组(n=10):对照组、酒精中毒模型组、酒精中毒+白藜芦醇甙低剂量组、酒精中毒+白藜芦醇甙高剂量组。以灌胃法(每天3.0 g/kg酒精)建立慢性酒精中毒大鼠模型。戒断评分法观察戒断症状;Morris水迷宫测试学习记忆成绩;免疫荧光法检测大鼠海马区Cdk5蛋白表达;液闪法检测海马组织Cdk5激酶活性。结果:酒精中毒模型组戒断评分、水迷宫测试结果、Cdk5激酶活性,均明显高于对照组(P0.05);白藜芦醇甙高剂量组戒断评分、水迷宫测试结果,均明显低于酒精中毒模型组(P0.05);白藜芦醇甙高低剂量组Cdk5激酶活性均明显低于酒精中毒模型组(P0.05);酒精中毒模型组大鼠海马区Cdk5阳性细胞较对照组明显增加(P0.05),给予白藜芦醇甙干预后Cdk5阳性细胞数量较酒精中毒模型组减少(P0.05)。结论:白藜芦醇甙能够缓解酒精中毒所致的记忆损伤,这种作用可能与下调Cdk5激酶活性有关。     

ΔFosB和Glu受体Ⅱ亚型与慢性可卡因成瘾

过去的一段时间里 ,ＣＲＥＢ一直被认为是与药物成瘾有密切关系的明星分子。但随着研究的不断深入发现 ,急性给予可卡因可引起ΔＦｏｓＢ家族的多种转录因子在伏核暂时性高表达 ,但慢性给予可卡因却可诱导Ｆｏｓ家族的异型体ΔＦｏｓＢ在伏核长期高表达 ,类似现象也见于反复给予其他成瘾性药物 ,因此ΔＦｏｓＢ遂脱颖而出成为又一个新星分子。 1 999年 9月在英国Ｎａｔｕｒｅ杂志发表的一篇文章报道 ,ΔＦｏｓＢ的表达增加及其引发的Ｇｌｕ受体Ⅱ亚型的增加可加强慢性给予可卡因引起的成瘾性 ,这可能与人类成瘾的形成相似。实验以一种转基因…     

GABA受体与药物依赖性的研究进展

药物成瘾是一种全球性的公共卫生问题,其发生机制十分复杂。γ-氨基丁酸(γ-aminobutyric acid,GABA)是中枢神经系统中主要的抑制性神经递质,其通过调节GABA受体(如:GABA_A,GABA_B)的活性参与多种药物成瘾和依赖性的发生与发展过程。吗啡、可卡因、甲基苯丙胺等药物引起的奖赏、戒断和复吸作用与GABA受体的激活或抑制密切相关。本文将对GABA受体在药物依赖中的作用及机制进行综述,从而为治疗药物成瘾提供新的策略。     

白介素-10抑制TNF-α诱导的血管平滑肌细胞增殖

研究观察了重组人白介素 10 (rhIL 10 )对肿瘤坏死因子 (TNF α)刺激的离体大鼠胸主动脉血管平滑肌细胞增殖、细胞周期及对p4 4 /p4 2丝裂素活化蛋白激酶的影响。实验培养大鼠主动脉血管平滑肌细胞 ,采用MTS/PES法确定血管平滑肌细胞 (vascularsmoothmusclecells,VSMCs)的增殖状态 ;应用流式细胞术测定细胞周期 ;利用p4 4 / 4 2磷酸化抗MAPK抗体的蛋白免疫印迹法测定MAPK蛋白表达。结果显示 :( 1)TNF α处理组与对照组相比 ,TNF α对VSMC增殖具有明显的刺激作用 (P <0 0 5 )。rhIL 10单独应用对VSMCs生长没有影响 (P >0 0 5 )。在TNF α刺激下 ,低至 10ng/ml的rhIL 10可抑制VSMCs的生长 (P <0 0 5 )。流式细胞术测定的结果显示 ,rhIL 10分别可使TNF α作用下的VSMC大部分处于G0 /G1期 ,与对照组相比有明显差异 (P <0 0 1)。 ( 2 )TNF α对p4 4 /p4 2MAPK蛋白表达有显著的增强作用 ,此作用可被rhIL 10抑制。结果提示 ,rhIL 10可抑制TNF α诱导的VSMC增殖及p4 4 /p4 2丝裂素活化蛋白激酶的表达     

Identification of tyrosine hydroxylase as a physiological substrate for Cdk5

Cyclin-dependent kinase 5 (Cdk5) is emerging as a neuronal protein kinase involved in multiple aspects of neurotransmission in both post- and presynaptic compartments. Within the reward/motor circuitry of the basal ganglia, Cdk5 regulates dopamine neurotransmission via phosphorylation of the postsynaptic signal transduction pathway integrator, DARPP-32 (dopamine- and cyclic AMP-regulated phosphoprotein, M(r) 32,000). Cdk5 has also been implicated in regulating various steps in the presynaptic vesicle cycle. Here we report that Cdk5 phosphorylates tyrosine hydroxylase (TH), the key enzyme for synthesis of dopamine. Using phosphopeptide mapping, site-directed mutagenesis, and phosphorylation state-specific antibodies, the site was identified as Ser31, a previously defined extracellular signal-regulated kinases 1/2 (ERK1/2) site. The phosphorylation of Ser31 by Cdk5 versus ERK1/2 was investigated in intact mouse striatal tissue using a pharmacological approach. The results indicated that Cdk5 phosphorylates TH directly and also regulates ERK1/2-dependent phosphorylation of TH through the phosphorylation of mitogen-activated protein kinase kinase 1 (MEK1). Finally, phospho-Ser31 TH levels were increased in dopaminergic neurons of rats trained to chronically self-administer cocaine. These results demonstrate direct and indirect regulation of the phosphorylation state of a Cdk5/ERK1/2 site on TH and suggest a role for these pathways in the neuroadaptive changes associated with chronic cocaine exposure.     

Expression of Cdk5 and its activators in NT2 cells during neuronal differentiation

We have recently developed a rapid protocol involving NT2 cell aggregation and treatment with retinoic acid (RA) to produce terminally differentiated CNS neurons. As a first step to explore the functional roles of cell-cycle regulatory proteins in the process of neuronal differentiation, the expression profiles of cyclin-dependent kinases (Cdks) and their regulators were examined in NT2 cells following treatment with RA. One of the Cdks, Cdk5, has been demonstrated to affect the process of neuronal differentiation and suggested to play an important role in development of the nervous system. We found that the expression of Cdk5 was gradually increased, while its activators (p35 and p39) as well as Cdk5 kinase activity were induced in NT2 cells during the process of neuronal differentiation. Moreover, both p35 and p39 were localized along the axons and varicosity-like structures of differentiated NT2 neurons. Taken together, our results demonstrated that NT2 cells provide a good in vitro model system to examine signaling pathways involved in the regulation of Cdk5 activators and to elucidate the functional roles of Cdk5 in neuronal differentiation.     

Alternative roles for Cdk5 in learning and synaptic plasticity

Protein kinases mediate the intracellular signal transduction pathways controlling synaptic plasticity in the central nervous system. While the majority of protein kinases achieve this function via the phosphorylation of synaptic substrates, some kinases may contribute through alternative mechanisms in addition to enzymatic activity. There is growing evidence that protein kinases may often play structural roles in plasticity as well. Cyclin-dependent kinase 5 (Cdk5) has been implicated in learning and synaptic plasticity. Initial scrutiny focused on its enzymatic activity using pharmacological inhibitors and genetic modifications of Cdk5 cofactors. Quite recently Cdk5 has been shown to govern learning and plasticity via regulation of glutamate receptor degradation, a function that may not dependent on phosphorylation of downstream effectors. From these new studies, two roles emerge for Cdk5 in plasticity: one in which it controls structural plasticity via phosphorylation of synaptic substrates, and a second where it regulates functional plasticity via protein-protein interactions.     

Evidence for amylase release by cyclin-dependent kinase 5 in the rat parotid

Cyclin-dependent kinase 5 (Cdk5) plays no apparent role in cell cycle regulation, and Cdk5 is not activated by cyclins but only p35 or p39. Although the enzymatic activity of Cdk5 is highest in the central nervous system, recent reports indicate that it also has important functions in non-neuronal cells. In the present study, we investigated whether Cdk5 and its activators are expressed in rat parotid acinar cells, whether a β-adrenergic agonist enhances the expression of Cdk5, and whether Cdk5 mediates amylase release. We found that Cdk5 and its activator, cyclin I, were expressed in rat parotid acinar cells, and that the expression of Cdk5 was enhanced by treatment of the cells with isoproterenol. Amylase release stimulated by isoproterenol was depressed by the addition of olomoucine, a Cdk5 inhibitor, or by the introduction of an anti-Cdk5 antibody. Cdk5 activity was enhanced by treatment with isoproterenol and this enhanced activity was attenuated by the addition of olomoucine. Olomoucine also attenuated both phosphorylation of Munc18c and translocation of Munc18c from the plasma membrane induced by isoproterenol. These results indicated that β-stimulation of rat parotid acinar cells enhanced the expression of Cdk5, and that this Cdk5 activation may mediate amylase release through phosphorylation of Munc18c.     

Phosphorylation of Cyclin-dependent Kinase 5 (Cdk5) at Tyr-15 Is Inhibited by Cdk5 Activators and Does Not Contribute to the Activation of Cdk5

Cdk5 is a member of the cyclin-dependent kinase (Cdk) family. In contrast to other Cdks that promote cell proliferation, Cdk5 plays a role in regulating various neuronal functions, including neuronal migration, synaptic activity, and neuron death. Cdks responsible for cell proliferation need phosphorylation in the activation loop for activation in addition to binding a regulatory subunit cyclin. Cdk5, however, is activated only by binding to its activator, p35 or p39. Furthermore, in contrast to Cdk1 and Cdk2, which are inhibited by phosphorylation at Tyr-15, the kinase activity of Cdk5 is reported to be stimulated when phosphorylated at Tyr-15 by Src family kinases or receptor-type tyrosine kinases. We investigated the activation mechanism of Cdk5 by phosphorylation at Tyr-15. Unexpectedly, however, it was found that Tyr-15 phosphorylation occurred only on monomeric Cdk5, and the coexpression of activators, p35/p25, p39, or Cyclin I, inhibited the phosphorylation. In neuron cultures, too, the activation of Fyn tyrosine kinase did not increase Tyr-15 phosphorylation of Cdk5. Further, phospho-Cdk5 at Tyr-15 was not detected in the p35-bound Cdk5. In contrast, expression of active Fyn increased p35 in neurons. These results indicate that phosphorylation at Tyr-15 is not an activation mechanism of Cdk5 but, rather, indicate that tyrosine kinases could activate Cdk5 by increasing the protein amount of p35. These results call for reinvestigation of how Cdk5 is regulated downstream of Src family kinases or receptor tyrosine kinases in neurons, which is an important signaling cascade in a variety of neuronal activities.     

Neurodegeneration in an Aβ-induced model of Alzheimer's disease: the role of Cdk5

Cdk5 dysregulation is a major event in the neurodegenerative process of Alzheimer's disease (AD). In vitro studies using differentiated neurons exposed to Aβ exhibit Cdk5-mediated tau hyperphosphorylation, cell cycle re-entry and neuronal loss. In this study we aimed to determine the role of Cdk5 in neuronal injury occurring in an AD mouse model obtained through the intracerebroventricular (icv) injection of the Aβ_1–40 synthetic peptide. In mice icv-injected with Aβ, Cdk5 activator p35 is cleaved by calpains, leading to p25 formation and Cdk5 overactivation. Subsequently, there was an increase in tau hyperphosphorylation, as well as decreased levels of synaptic markers. Cell cycle reactivation and a significant neuronal loss were also observed. These neurotoxic events in Aβ-injected mice were prevented by blocking calpain activation with MDL28170 , which was administered intraperitoneally (ip). As MDL prevents p35 cleavage and subsequent Cdk5 overactivation, it is likely that this kinase is involved in tau hyperphosphorylation, cell cycle re-entry, synaptic loss and neuronal death triggered by Aβ. Altogether, these data demonstrate that Cdk5 plays a pivotal role in tau phosphorylation, cell cycle induction, synaptotoxicity, and apoptotic death in postmitotic neurons exposed to Aβ peptides in vivo , acting as a link between diverse neurotoxic pathways of AD.     

Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35

Cyclin-dependent kinase 5 (Cdk5) is a proline-directed Ser/Thr kinase that plays important roles in various neuronal activities, including neuronal migration, synaptic activity, and neuronal cell death. Cdk5 is activated by association with a neuron-specific activator, p35 or its isoform p39, but little is known about the kinase activity of Cdk5--p39. In fact, kinase-active Cdk5--p39 was not prepared from rat brain extracts nor from HEK293 cells expressing Cdk5 and p39 by immunoprecipitation in the presence of non-ionic detergent, under conditions with which active Cdk5--p35 could be isolated. p39 dissociated from Cdk5 in the presence of detergent, indicating that p39 has a lower binding affinity for Cdk5 than p35. We developed a method for purifying kinase-active Cdk5--p39 from Sf9 cells infected with baculovirus encoding Cdk5 and p39. The purified Cdk5--p39 complex showed similar substrate specificity to that of Cdk5--p35, but with opposite sensitivity to detergent. Cdk5--p39 was inactivated by Triton X-100, whereas Cdk5--p35 was activated. The N-terminal deletion from p35 and p39, the amino acid sequences of which are different, did not change the stability or substrate specificity of either Cdk5 complex. The different stability between Cdk5--p35 and Cdk5--p39 suggests their distinct roles under different regulation mechanisms in neurons.